Search Results
Results found for "positive allosteric modulators"
- ADGRL3 genomic variation implicated in neurogenesis and ADHD links functional effects to the...
October 2022 ADGRL3 genomic variation implicated in neurogenesis and ADHD links functional effects to the incretin polypeptide GIP "Attention deficit/hyperactivity disorder (ADHD) is the most common childhood neurodevelopmental disorder. Single nucleotide polymorphisms (SNPs) in the Adhesion G Protein-Coupled Receptor L3 (ADGRL3) gene are associated with increased susceptibility to developing ADHD worldwide. However, the effect of ADGRL3 non-synonymous SNPs (nsSNPs) on the ADGRL3 protein function is vastly unknown. Using several bioinformatics tools to evaluate the impact of mutations, we found that nsSNPs rs35106420, rs61747658, and rs734644, previously reported to be associated and in linkage with ADHD in disparate populations from the world over, are predicted as pathogenic variants. Docking analysis of rs35106420, harbored in the ADGLR3-hormone receptor domain (HRM, a common extracellular domain of the secretin-like GPCRs family), showed that HRM interacts with the Glucose-dependent insulinotropic polypeptide (GIP), part of the incretin hormones family. GIP has been linked to the pathogenesis of diabetes mellitus, and our analyses suggest a potential link to ADHD. Overall, the comprehensive application of bioinformatics tools showed that functional mutations in the ADGLR3 gene disrupt the standard and wild ADGRL3 structure, most likely affecting its metabolic regulation. Further in vitro experiments are granted to evaluate these in silico predictions of the ADGRL3-GIP interaction and dissect the complexity underlying the development of ADHD." Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, April 24 to 30, 2023
GPCR Binders, Drugs, and more Allosteric modulation of a human odorant receptor. assays allow the analysis of binding kinetics of WNT-3A to endogenous Frizzled 7 in a colorectal cancer model
- Cholesterol occupies the lipid translocation pathway to block phospholipid scrambling by a GPCR
Our previous Markov State Model (MSM) analysis of molecular dynamics simulations of membrane-embedded
- 📰 GPCR Weekly News, August 14 to 20, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities'. Target - DOT (September 25 - 28, 2023) Training Seminar "The Renaissance in GPCRs as Drug Targets: Allosteric Interactions of GPCRs, Ion Channels, and Transport Proteins (March 24 - 29, 2024) GPCR Jobs NEW PhD Student Position
- 📰 GPCR Weekly News, August 7 to 13, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities'. Want to share your project in a casual way? Target - DOT (September 25 - 28, 2023) Training Seminar "The Renaissance in GPCRs as Drug Targets: Allosteric
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
Previous pharmacophore modeling studies of the β3 -AR did not involve experimental in vitro validation Ligand-based pharmacophore modeling was performed since no 3D structure of human β3 -AR is yet available A dataset consisting of β3 -AR agonists was prepared to build and validate the pharmacophore models. The best model was employed for prospective virtual screening, followed by physicochemical property filtering
- 📰 GPCR Weekly News, September 18 to 24, 2023
GPCR Symposium about 'GPCRs as Therapeutic Modalities' rocked it! Binders, Drugs, and more An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric functional survival of human islets AT2 receptor agonist LP2 restores respiratory function in a rat model Clinical Research NEW Scientist (level I or II) NEW Research Fellow Research Technician II - Surgery Post-Doc
- 📰 GPCR Weekly News, December 18 to 31, 2023
We’ve curated 23 GPCR papers, four industry news, and 3 GPCR job posts! This week's highlight: Drs. Tribolium castaneum GPCR Activation and Signaling Palmitoylation of the Glucagon-like Peptide-1 Receptor Modulates Measure Receptor-Ligand Interactions How accurately can one predict drug binding modes using AlphaFold models duplications linked to phloem feeding Structural and Molecular Insights into GPCR Function Studying allosteric Associate Scientist Postdoctoral Scholar - O’Neill Lab Junior Research Scientist Postdoctoral Fellow Post-Doc
- 📰 GPCR Weekly News, December 4 to 10, 2023
course covers fundamental pharmacology in four weekly segments, delving into Agonists, Antagonists, and Allosteric Modulators. | 20th World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs NEW Postdoctoral Fellow NEW Post-Doc
- 📰 GPCR Weekly News, February 13 to 19, 2023
Mandibulofacial dysostosis with alopecia results from ETAR gain-of-function mutations via allosteric Structural and Molecular Insights into GPCR Function Quantitative analysis of sterol-modulated monomer-dimer Protein Biochemistry) Speculative Applications (Mass Spectrometry) Speculative Applications (Chemistry) Post-Doctoral
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
previously demonstrated rescue of cell surface expression of luteinizing hormone receptor mutants by an allosteric
- 📰 GPCR Weekly News, July 17 to July 23, 2023
GPCR Symposium on GPCRs as Therapeutic Modalities on September 22nd. Updates in GPCR Research Fluorescent Ligands Enable Target Engagement Studies for the Intracellular Allosteric
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
This high-resolution mapping can confirm the protein’s role in disease pathology and highlight allosteric The choice of model systems, such as yeast, bacteria, or mammalian cells, can heavily influence the method's Certain systems might not replicate the natural environment or post-translational modifications observed Additionally, combining DMS with computational modelling and machine learning algorithms promises to
- 📰 GPCR Weekly News, May 29 to June 4, 2023
This week, we would like to highlight two new publications: Pharmacological hallmarks of allostery at GPCRs in Neuroscience DRD1 signaling modulates TrkB turnover and BDNF sensitivity in direct pathway striatal Structure-based pharmacophore modeling 1. Automated random pharmacophore model generation. Structural and Molecular Insights into GPCR Function Pharmacological hallmarks of allostery at the M4 November 2 - 4, 2023) GPCR Jobs NEW Senior Vice President of Global Medical Affairs NEW Postdoctoral Position
- 📰 GPCR Weekly News, February 20 to 26, 2023
Allosteric modulation of conserved motifs and helices in 5HT2BR: Advances drug discovery and therapeutic
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Senior Scientist/Staff Scientist, Computational Chemistry Postdoc in GPCR mechanosensing  Postdoctoral Position antagonist Probing the energy landscape of the lipid interactions of the serotonin1A receptor Potential allosteric
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
vs Deep Learning GPCRs have long been recognized as important drug targets, and numerous drugs that modulate ML algorithms typically use traditional ML models, such as decision trees and support vector machines which comprise handcrafted features and simpler models. For this reason, DL models generally require more computational resources (such as powerful GPUs) and sites (orthosteric, allosteric), activation mechanisms, and conformational changes. 8.
- 📰 GPCR Weekly News, August 28 to September 3, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities' Showcase your project with a 1-minute abstract video Discovery On Target September 27 - 28, 2023 | Training Seminar "The Renaissance in GPCRs as Drug Targets: Allosteric
- 📰 GPCR Weekly News - January 2 to 8, 2023
Updates in GPCR Research Small Molecule Tools to Study Cellular Target Engagement for the Intracellular Allosteric
- Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist...
) that mediate stronger signaling in mouse versus human GPR116 and recapitulate these findings in a model
- Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research
A bibliographic search accompanied by in silico modelling is essential to determine the appropriate The pharmacophore is then functionalized in the best position for introducing a linker. Orthosteric and Allosteric Action of the C5a Receptor Antagonists.
- β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during..
September 2022 β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during Collagen-Induced Arthritis "The sympathetic nervous system (SNS) has either a pro-inflammatory or anti-inflammatory effect, depending on the stage of arthritis. In the past, treatment of arthritic B cells with a β2-adrenergic receptor (β2-ADR) agonist has been shown to attenuate arthritis. In this study, the expression and signaling of β2-ADR in B cells during collagen-induced arthritis (CIA) were investigated to provide an explanation of why only B cells from arthritic mice are able to improve CIA. Splenic B cells were isolated via magnetic-activated cell sorting (MACS). Adrenergic receptors on B cells and intracellular β2-ADR downstream molecules (G protein-coupled receptor kinase 2 (GRK-2), β-Arrestin 2, p38 MAPK, extracellular signal-regulated kinase 1/2 (ERK1/2) and cAMP response element-binding protein (CREB)) were analyzed at different time points in naïve and arthritic B cells with and without stimulation of β2-ADR agonist terbutaline by flow cytometry. β2-ADR-expressing B cells increase during CIA without a change in receptor density. Moreover, we observed a profound downregulation of GRK-2 shortly after induction of arthritis and an increase in β-Arrestin 2 only at late stage of arthritis. The second messengers studied (p38, ERK1/2 and CREB) followed a biphasic course, characterized by a reduction at onset and an increase in established arthritis. Stimulation of CIA B cells with the β-ADR agonist terbutaline increased pp38 MAPK independent of the timepoint, while pERK1/2 and pCREB were enhanced only in the late phase of arthritis. The phosphorylation of p38 MAPK, ERK1/2 and CREB in the late phase of arthritis was associated with increased IL-10 produced by B10 cells. The change of β2-ADR expression and signaling during sustained inflammation might be an integral part of the switch from pro- to anti-inflammatory action of sympathetic mechanisms in late arthritis." Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
β-arrestin-1 revealed by 19F NMR spectroscopy Role of protease activated receptor 4 (PAR4) in mouse models proliferation of T-cell lymphoma cells through the enhancement of apoptosis Methods & Updates in GPCR Research Modulating Fully activated structure of the sterol-bound Smoothened GPCR-Gi protein complex Deep Learning Dynamic Allostery oncology biomarker expert NEW Postdoctoral Fellow NEW Scientific Assistant Scientist Lead Researcher Post-Doctoral Fellow Sr Scientist in Obesity, Muscle, and Metabolism Post-Doctoral Fellow Explore Dr.
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
Learn binding, bias, kinetics, and core models—fundamentals that fuel confidence and fluency Move beyond apply selectivity, ADME, and early safety in real development contexts Advance with nuanced lessons on allostery This blog post breaks down Dr.
- 📰 GPCR Weekly News, March 6 to 12, 2023
Neuroscience Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease mouse model Intermediate-state-trapped mutants pinpoint G protein-coupled receptor conformational allostery. Structural and Molecular Insights into GPCR Function Endogenous l- to d-amino acid residue isomerization modulates
- GPCR Buzz of the Week | Sep 23 - 29, 2024
Modules: October 31st : The Eyes to See- The Importance of Pharmacologic Assays. Senior Scientist/Staff Scientist, Computational Chemistry Postdoc in GPCR mechanosensing  Postdoctoral Position Postdoctoral research position Adhesion GPCRs The G Protein-Coupled Receptor GPR56 Is an Inhibitory Strategy to Enhance Azobenzene-Based Photopharmacology GPCRs in Cardiology, Endocrinology, and Taste Rap1A Modulates structure of human class C orphan GPCR GPR179 involved in visual processing Reliability of AlphaFold2 Models
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
(Bikker et al., 1998) Quantitative studies of how drugs modulate their targets have been instrumental with novel specificity high-throughput selection, has been used to identify specificity-determining positions Integrating mutagenesis data with computational models also presents challenges, requiring high-quality allowing researchers to determine the functional consequences of every possible amino acid change at each position G-protein coupled receptors: models, mutagenesis, and drug design.
- The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology
Venetia Zachariou  introduced him to the power of RGS proteins — particularly RGS4  — in modulating pain recovery that is very rare to see at the preclinical level. " Such recovery is rare in preclinical pain models and hints that RGS proteins could modulate pain chronification itself .
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Senior Scientist/Staff Scientist, Computational Chemistry Postdoc in GPCR mechanosensing  Postdoctoral Position Postdoctoral research position GPCR Activation and Signaling Germline mutations in a G protein identify signalling profiles GPCRs in Cardiology, Endocrinology, and Taste Cyclic adenosine monophosphate critically modulates of fingolimod (FTY720) and desensitization of S1P1 receptor-mediated G-protein activation in a mouse model Architecture and Positive Sample Machine Learning Strategies Reviews, GPCRs, and more GPCR Biosensors
- 📰 GPCR Weekly News, April 22 to 28, 2024
Our Chief Matchmaker, Mark Schmeizl, had a great conversation about this position with Beth Fleck, Director Signaling at the Endosome GPCR Binders, Drugs, and more Discovery and development of macrocyclic peptide modulators RNA NEAT1 in Alzheimer's disease Parenting behaviors in mice: Olfactory mechanisms and features in models Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs NEW Post Doctoral Fellow Postdoc Position Principal Scientist, In vitro pharmacology Senior Associate Scientist









